Cite
HARVARD Citation
Tong, W. et al. (2016). Liraglutide ameliorates non‐alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1/SIRT3–FOXO3a pathway. Hepatology research. 46 (9), pp. 933-943. [Online].